Sequelae of Ebola virus disease: the emergency within the emergency

The Lancet Infectious Diseases

Volumn 16, Issue 6, 2016, Pages e82-e91

  Vetter, Pauline ^a,b   Kaiser, Laurent ^a,c   Schibler, Manuel ^a   Ciglenecki, Iza ^b   Bausch, Daniel G ^d  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

AFRICA; ARTHRALGIA; BREAST MILK; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONJUNCTIVITIS; CONVALESCENCE; DISEASE COURSE; DISEASE TRANSMISSION; EBOLA HEMORRHAGIC FEVER; EMERGENCY; EPIDEMIC; EYE PAIN; FETUS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEARING IMPAIRMENT; HUMAN; HYPERLACRIMATION; INFECTION RISK; LACRIMATION DISORDER; MENTAL DISEASE; NEUROLOGICAL COMPLICATION; PATIENT CARE; PHOTOPHOBIA; POLYARTHRITIS; PRACTICE GUIDELINE; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; SKIN DISEASE; SOCIAL WELFARE; SPERM; SPONDYLARTHRITIS; SURVIVOR; TINNITUS; UVEITIS; VIRAL CLEARANCE; VISUAL DISORDER; COMPLICATION; DISEASE OUTBREAKS; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; ISOLATION AND PURIFICATION; PATHOPHYSIOLOGY; PSYCHOLOGY;

AFRICA, WESTERN; ARTHRALGIA; DISEASE OUTBREAKS; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; SURVIVORS; UVEITIS;

EID: 84962610881     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)00077-3     Document Type: Review

References (78)

1. 1 WHO. Ebola response roadmap situation report, 2015, World Health Organization, Geneva http://apps.who.int/ebola/current-situation/ebola-situation-report-30-december-2015 (accessed Dec 30, 2015).
2. 2 Emond, RT, Evans, B, Bowen, ET, Lloyd, G, A case of Ebola virus infection. BMJ 2 (1977), 541–544.
3. 3 Formenty, P, Hatz, C, Le Guenno, B, Stoll, A, Rogenmoser, P, Widmer, A, Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation. J Infect Dis 179:suppl 1 (1999), S48–S53.
4. 4 Bwaka, MA, Bonnet, MJ, Calain, P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 179:suppl 1 (1999), S1–S7.
5. 5 De Roo, A, Ado, B, Rose, B, Guimard, Y, Fonck, K, Colebunders, R, Survey among survivors of the 1995 Ebola epidemic in Kikwit, Democratic Republic of Congo: their feelings and experiences. Trop Med Int Health 3 (1998), 883–885.
6. 6 Kibadi, K, Mupapa, K, Kuvula, K, et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis 179:suppl 1 (1999), S13–S14.
7. 7 Rowe, AK, Bertolli, J, Khan, AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis 179:suppl 1 (1999), S28–S35.
8. 8 Wendo, C, Caring for the survivors of Uganda's Ebola epidemic one year on. Lancet, 358, 2001, 1350.
9. 9 Clark, DV, Kibuuka, H, Millard, M, et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis 15 (2015), 905–912.
10. 10 Mohammed, A, Sheikh, TL, Gidado, S, et al. An evaluation of psychological distress and social support of survivors and contacts of Ebola virus disease infection and their relatives in Lagos, Nigeria: a cross sectional study—2014. BMC Public Health, 15, 2015, 824.
11. 11 Qureshi, AI, Chughtai, M, Loua, TO, et al. Study of Ebola virus disease survivors in Guinea. Clin Infect Dis 61 (2015), 1035–1042.
12. 12 Epstein, L, Wong, KK, Kallen, AJ, Uyeki, TM, Post-Ebola signs and symptoms in U.S. survivors. N Engl J Med 373 (2015), 2484–2486.
13. 13 Christie, A, Davies-Wayne, GJ, Cordier-Lassalle, T, et al. Possible sexual transmission of Ebola virus—Liberia, 2015. MMWR Morb Mortal Wkly Rep 64 (2015), 479–481.
14. 14 Jampol, LM, Ferris, FL 3rd, Bishop, RJ, Ebola and the eye. JAMA Ophthalmol 133 (2015), 1105–1106.
15. 15 Mate, SE, Kugelman, JR, Nyenswah, TG, et al. Molecular evidence of sexual transmission of Ebola virus. N Engl J Med 373 (2015), 2448–2454.
16. 16 Hugo, M, Declerck, H, Fitzpatrick, G, et al. Post-traumatic stress reactions in Ebola virus disease survivors in Sierra Leone. Emerg Med 5 (2015), 1–4.
17. 17 Howlett, P, Brown, C, Helderman, T, et al. Ebola virus disease complicated by late-onset encephalitis and polyarthritis, Sierra Leone [letter]. Emerg Infect Dis 22 (2016), 150–152.
18. 18 Mattia, JGVM, Vandy, MJ, Chang, JC, et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis 16 (2015), 331–338.
19. 19 Nanyonga, M, Saidu, J, Ramsay, A, Shindo, N, Bausch, DG, Sequelae of Ebola virus disease, Kenema District, Sierra Leone. Clin Infect Dis 62 (2016), 125–126.
20. 20 Mora-Rillo, M, Arsuaga, M, Ramírez-Olivencia, G, et al. Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain. Lancet Respir Med 3 (2015), 554–562.
21. 21 Chancellor, JR, Padmanabhan, SP, Greenough, TC, et al. Uveitis and systemic inflammatory markers in convalescent phase of Ebola virus disease. Emerg Infect Dis 22 (2016), 295–297.
22. 22 Varkey, JB, Shantha, JG, Crozier, I, et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med 372 (2015), 2423–2427.
23. 23 Liddell, AM, Davey, RT Jr, Mehta, AK, et al. Characteristics and clinical management of a cluster of 3 patients with Ebola virus disease, including the first domestically acquired cases in the United States. Ann Intern Med 163 (2015), 81–90.
24. 24 Bausch, DG, Sequelae after Ebola virus disease: even when it's over it's not over. Lancet Infect Dis 15 (2015), 865–866.
25. 25 Dhillon, P, McCarthy, S, Gibbs, M, Surviving stroke in an Ebola treatment centre. BMJ Case Rep, 2015 PII:bcr2015211062.
26. 26 Dallatomasina, S, Crestani, R, Sylvester Squire, J, et al. Ebola outbreak in rural west Africa: epidemiology, clinical features and outcomes. Trop Med Int Health 20 (2015), 448–454.
27. 27 Nkoghe, D, Leroy, EM, Toung-Mve, M, Gonzalez, JP, Cutaneous manifestations of filovirus infections. Int J Dermatol 51 (2012), 1037–1043.
28. 28 Schieffelin, JS, Shaffer, JG, Goba, A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 371 (2014), 2092–2100.
29. 29 Kreuels, B, Wichmann, D, Emmerich, P, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med 371 (2014), 2394–2401.
30. 30 McElroy, AK, Akondy, RS, Davis, CW, et al. Human Ebola virus infection results in substantial immune activation. Proc Natl Acad Sci USA 112 (2015), 4719–4724.
31. 31 Towner, JS, Rollin, PE, Bausch, DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 78 (2004), 4330–4341.
32. 32 Geisbert, TW, Jahrling, PB, Larsen, T, Davis, KJ, Hensley, LE, Filovirus pathogenesis in nonhuman primates. Klenk, H-D, Feldmann, H, (eds.) Ebola and Marburg viruses: molecular and cellular biology, 2004, Horizon Bioscience, Norfolk, 203–238.
33. 33 Martines, RB, Ng, DL, Greer, PW, Rollin, PE, Zaki, SR, Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol 235 (2015), 153–174.
34. 34 Larsen, T, Stevens, EL, Davis, KJ, et al. Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus. J Infect Dis 196:suppl 2 (2007), S323–S328.
35. 35 Alves, DA, Honko, AN, Kortepeter, MG, et al. Necrotizing scleritis, conjunctivitis, and other pathologic findings in the left eye and brain of an Ebola virus-infected rhesus macaque (Macaca mulatta) with apparent recovery and a delayed time of death. J Infect Dis 213 (2016), 57–60.
36. 36 Gasque, P, Couderc, T, Lecuit, M, Roques, P, Ng, LF, Chikungunya virus pathogenesis and immunity. Vector Borne Zoonotic Dis 15 (2015), 241–249.
37. 37 Hoarau, JJ, Jaffar Bandjee, MC, Krejbich Trotot, P, et al. Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol 184 (2010), 5914–5927.
38. 38 Shultz, JM, Baingana, F, Neria, Y, The 2014 Ebola outbreak and mental health: current status and recommended response. JAMA 313 (2015), 567–568.
39. 39 Evans, DK, Popova, A, West African Ebola crisis and orphans. Lancet 385 (2015), 945–946.
40. 40 Reardon, S, Ebola's mental-health wounds linger in Africa. Nature 519 (2015), 13–14.
41. 41 WHO. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 56 (1978), 271–293.
42. 42 Hewlett, BS, Amola, RP, Cultural contexts of Ebola in northern Uganda. Emerg Infect Dis 9 (2003), 1242–1248.
43. 43 Arwady, MA, Garcia, EL, Wollor, B, et al. Reintegration of ebola survivors into their communities—Firestone District, Liberia, 2014. MMWR Morb Mortal Wkly Rep 63 (2014), 1207–1209.
44. 44 Gidado, S, Oladimeji, AM, Roberts, AA, et al. Public knowledge, perception and source of information on Ebola virus disease—Lagos, Nigeria; September, 2014. PLoS Curr, 7, 2015, 7.
45. 45 AllAfrica, Sierra Leone: As Ebola clocks one year…president pledges to support survivors. http://allafrica.com/stories/201505260286.html, May 26, 2015 (accessed June 7, 2015).
46. 46 Matua, GA, Wal, DM, Living under the constant threat of Ebola: a phenomenological study of survivors and family caregivers during an Ebola outbreak. J Nurs Res 23 (2015), 217–224.
47. 47 WHO. Clinical care for survivors of Ebola virus disease. Interim guidance. http://apps.who.int/csr/resources/publications/ebola/guidance-survivors/en/index.html, 2016 (accessed Jan 24, 2016).
48. 48 Lee-Kwan, SH, DeLuca, N, Adams, M, et al. Support services for survivors of ebola virus disease—Sierra Leone, 2014. MMWR Morb Mortal Wkly Rep 63 (2014), 1205–1206.
49. 49 Bausch, DG, Bangura, J, Garry, RF, et al. A tribute to Sheik Humarr Khan and all the healthcare workers in west Africa who have sacrificed in the fight against Ebola virus disease: Mae we hush. Antiviral Res 111 (2014), 33–35.
50. 50 Colebunders, RL, Cannon, RO, Large-scale convalescent blood and plasma transfusion therapy for Ebola virus disease. J Infect Dis 211 (2015), 1208–1210.
51. 51 Rodríguez-Vega, B, Amador, B, Ortiz-Villalobos, A, et al. The psychosocial response to the Ebola health emergency: experience in Madrid, Spain. Clin Infect Dis 60 (2015), 1866–1867.
52. 52 Smith, J, Boulton, J, Walker, E, Ebola survivor Will Pooley honoured at BJN Awards. Br J Nurs, 24, 2015, 316.
53. 53 Greenberg, N, Wessely, S, Wykes, T, Potential mental health consequences for workers in the Ebola regions of west Africa—a lesson for all challenging environments. J Ment Health 24 (2015), 1–3.
54. 54 Smith, CL, Hughes, SM, Karwowski, MP, et al. Addressing needs of contacts of Ebola patients during an investigation of an Ebola cluster in the United States—Dallas, Texas, 2014. MMWR Morb Mortal Wkly Rep 64 (2015), 121–123.
55. 55 Bausch, DG, Towner, JS, Dowell, SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 196:suppl 2 (2007), S142–S147.
56. 56 Formenty, P, Leroy, EM, Epelboin, A, et al. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 42 (2006), 1521–1526.
57. 57 Lyon, GM, Mehta, AK, Varkey, JB, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 371 (2014), 2402–2409.
58. 58 Richards, GA, Murphy, S, Jobson, R, et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med 28 (2000), 240–244.
59. 59 Rodriguez, LL, De Roo, A, Guimard, Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 179:suppl 1 (1999), S170–S176.
60. 60 Schibler, M, Vetter, P, Cherpillod, P, et al. Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report. Lancet Infect Dis 15 (2015), 1034–1040.
61. 61 Wolf, T, Kann, G, Becker, S, et al. Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care. Lancet 385 (2015), 1428–1435.
62. 62 Deen, GF, Knust, B, Broutet, N, et al. Ebola RNA persistence in semen of Ebola virus disease survivors—preliminary report. N Engl J Med, 2015, 10.1056/NEJMoa1511410 published online Oct 14.
63. 63 Eggo, RM, Watson, CH, Camacho, A, Kucharski, AJ, Funk, S, Edmunds, WJ, Duration of Ebola virus RNA persistence in semen of survivors: population-level estimates and projections. Euro Surveill 20 (2015), 1–6.
64. 64 Gear, JS, Cassel, GA, Gear, AJ, et al. Outbreake of Marburg virus disease in Johannesburg. BMJ 4 (1975), 489–493.
65. 65 Kuming, BS, Kokoris, N, Uveal involvement in Marburg virus disease. Br J Ophthalmol 61 (1977), 265–266.
66. 66 Akerlund, E, Prescott, J, Tampellini, L, Shedding of Ebola virus in an asymptomatic pregnant woman. N Engl J Med 372 (2015), 2467–2469.
67. 67 Baggi, FM, Taybi, A, Kurth, A, et al. Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014. Euro Surveill 19 (2014), 1–4.
68. 68 Mupapa, K, Mukundu, W, Bwaka, MA, et al. Ebola hemorrhagic fever and pregnancy. J Infect Dis 179:suppl 1 (1999), S11–S12.
69. 69 Oduyebo, T, Pineda, D, Lamin, M, Leung, A, Corbett, C, Jamieson, DJ, A pregnant patient with Ebola virus disease. Obstet Gynecol 126 (2015), 1273–1275.
70. 70 Bower, H, Grass, JE, Veltus, E, et al. Delivery of an Ebola virus-positive stillborn infant in a rural community health center, Sierra Leone, 2015. Am J Trop Med Hyg 94 (2016), 417–419.
71. 71 Nelson, JM, Griese, SE, Goodman, AB, Peacock, G, Live neonates born to mothers with Ebola virus disease: a review of the literature. J Perinatol, 2015, 10.1038/jp.2015.189 published online Dec 10.
72. 72 Caluwaerts, S, Fautsch, T, Lagrou, D, et al. Dilemmas in managing pregnant women with Ebola: 2 case reports. Clin Infect Dis 62 (2016), 93–105.
73. 73 Nordenstedt, H, Bah, I, de la Vega, M, et al. Ebola virus in breast milk in an Ebola virus–positive mother with twin babies, Guinea, 2015. Emerg Infect Dis, 2016, 10.3201/eid2204.151880 published online Jan 21.
74. 74 Griffin, DE, Lin, WH, Pan, CH, Measles virus, immune control, and persistence. FEMS Microbiol Rev 36 (2012), 649–662.
75. 75 World Health Organization. 2015. Interim advice on the sexual transmission of the Ebola virus disease. http://www.who.int/reproductivehealth/topics/rtis/ebola-virus-semen/en/ (accessed May 26, 2015).
76. 76 World Health Organization. 2015. Interim Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-Care Settings, with Focus on Ebola. http://apps.who.int/iris/bitstream/10665/130596/1/WHO_HIS_SDS_2014.4_eng.pdf?ua=1 (accessed Jan 24, 2016).
77. 77 World Health Organization. 2015. Ebola virus disease in pregnancy: screening and management of Ebola cases, contacts and survivors. http://www.who.int/csr/resources/publications/ebola/pregnancy-guidance/en/ (accessed Sept 18, 2015).
78. 78 World Health Organization. 2014. Nutritional care of children and adults with Ebola virus disease in treatment centres. http://www.who.int/elena/titles/full_recommendations/nutrition_ebola/en/index4.html (accessed Nov 2, 2015).